Richard Paulson - President and CEO, Karyopharm Therapeutics Inc

As of June 8, 2022


What is Richard Paulson's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's President and CEO, Richard Paulson, is estimated to be about $2.26M . Richard Paulson owns about 630,906 units of Karyopharm Therapeutics Inc common stock. In the last 2 years at Karyopharm Therapeutics Inc, Richard Paulson has sold an estimated value of $14.64K worth.

What is Richard Paulson's Past Insider Trading?

Richard Paulson's largest sale order was 2,542 units , worth over $14.64K on June 8, 2022. In total, Richard Paulson has made about 5 transactions over 2 years of their time at Karyopharm Therapeutics Inc. Richard Paulson usually trades in March and May, with the busiest year in 2022 and 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Richard Paulson's' Mailing Address?

  • Mailing address is 85 Wells Avenue Newton MA 02459 MA

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on June 14, 2022 by Sohanya Cheng who sold 1,551 units worth $8.07K . In the last 9 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $147.74M and bought an estimated value of $33.43M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1